RADX Annual EBIT
-$30.95 M
-$7.75 M-33.39%
01 June 2024
Summary:
As of January 30, 2025, RADX annual earnings before interest & taxes is -$30.95 million, with the most recent change of -$7.75 million (-33.39%) on June 1, 2024. During the last 3 years, it has fallen by -$15.76 million (-103.78%). RADX annual EBIT is now -103.78% below its all-time high of -$13.03 million.RADX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RADX EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -33.4% | - | - |
| 3 y3 years | -103.8% | - | - |
| 5 y5 years | -103.8% | - | - |
RADX EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -103.8% | at low | ||||
| 5 y | 5-year | -103.8% | at low | ||||
| alltime | all time | -103.8% | at low |
Radiopharm Theranostics Limited EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | -$30.95 M(+33.4%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | -$23.20 M(+52.8%) | - | - |
| June 2022 | -$15.19 M | - | - |
FAQ
- What is Radiopharm Theranostics Limited annual earnings before interest & taxes?
- What is the all time high annual EBIT for Radiopharm Theranostics Limited?
- What is Radiopharm Theranostics Limited annual EBIT year-on-year change?
What is Radiopharm Theranostics Limited annual earnings before interest & taxes?
The current annual EBIT of RADX is -$30.95 M
What is the all time high annual EBIT for Radiopharm Theranostics Limited?
Radiopharm Theranostics Limited all-time high annual earnings before interest & taxes is -$13.03 M
What is Radiopharm Theranostics Limited annual EBIT year-on-year change?
Over the past year, RADX annual earnings before interest & taxes has changed by -$7.75 M (-33.39%)